ArticleClinical cancer research : an official journal of the American Association for Cancer Research2023

A Phase I/II Trial of HER2 Vaccine-Primed Autologous T-Cell Infusions in Patients with Treatment Refractory HER2-Overexpressing Breast Cancer.

Mary L Disis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.